HealthNet TPO   Report issue

Foundation Phase 2 Phase 3
Founded: Amsterdam Netherlands (1992)

Organization Overview

First Clinical Trial
2001
NCT00158548
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now